Loading the session
Loading the session
Loading instrument
$19.78
+1.54%Market closedDelayed 15 minutes · Source: ViewTrade · 4 Nov 2026, 06:30 IST · A quote does not mean the product is available to trade on your account.
In brief
Questions investors ask
Quotes run fifteen minutes behind.
The 3 Nov 2026 close of $19.56 was 1.3% below its 50-day average ($19.82) and 2.1% above its 200-day average ($19.15). It has closed above the 200-day for 2 sessions, since 2 Nov 2026. The 50-day average crossed above the 200-day on 27 May 2026, 111 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 3 Nov 2026
3 Nov 2026 volume of 9.9M shares was 1.6× the average of the 30 sessions before it (6.1M), as the price rose 0.4%. SPY traded 0.8× its own average that session.
Daily volume against a 30-session baseline · as of 3 Nov 2026
$0.1017 a share, payable 25 Nov 2026; unchanged from the previous payment (ex-date 19 Oct 2026).
Corporate actions record · as of 4 Nov 2026
1 month: +3.8% (SPY −2.6%, XLRE +7.4%). 3 months: −9.5% (SPY −2.2%, XLRE −3.3%). 1 year: +10.6% (SPY +10.4%, XLRE +7.0%). Price change to the 3 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: DOC, SPY and XLRE · as of 3 Nov 2026
Closed at $19.56 on 3 Nov 2026: 14.8% below the 52-week high of $22.95 (28 Jul 2026) and 24.6% above the low of $15.70 (28 Apr 2026).
Daily price bars, split-adjusted · as of 3 Nov 2026
Price return, split-adjusted
At the 3 Nov 2026 close
Healthpeak owns a diversified healthcare portfolio of nearly 700 in-place properties spread across mainly medical office and life science assets, plus a small portfolio of senior housing properties owned through the company's equity investment in Janus Living.
May 6, 2026
+18.11%March 4, 2024
+50.04%November 14, 2023
+8.57%